JPWO2020079448A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020079448A5 JPWO2020079448A5 JP2021546487A JP2021546487A JPWO2020079448A5 JP WO2020079448 A5 JPWO2020079448 A5 JP WO2020079448A5 JP 2021546487 A JP2021546487 A JP 2021546487A JP 2021546487 A JP2021546487 A JP 2021546487A JP WO2020079448 A5 JPWO2020079448 A5 JP WO2020079448A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- seq
- nucleic acid
- sequence
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022173369A JP7762132B2 (ja) | 2018-10-19 | 2022-10-28 | 新規な癌抗原及び方法 |
| JP2024212437A JP2025041678A (ja) | 2018-10-19 | 2024-12-05 | 新規な癌抗原及び方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18201634.5 | 2018-10-19 | ||
| EP18201634 | 2018-10-19 | ||
| PCT/GB2019/052980 WO2020079448A1 (en) | 2018-10-19 | 2019-10-18 | Novel cancer antigens and methods |
Related Child Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022173369A Division JP7762132B2 (ja) | 2018-10-19 | 2022-10-28 | 新規な癌抗原及び方法 |
| JP2024212437A Division JP2025041678A (ja) | 2018-10-19 | 2024-12-05 | 新規な癌抗原及び方法 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2022514116A JP2022514116A (ja) | 2022-02-09 |
| JPWO2020079448A5 true JPWO2020079448A5 (https=) | 2022-11-10 |
| JP2022514116A5 JP2022514116A5 (https=) | 2022-11-10 |
| JP7712207B2 JP7712207B2 (ja) | 2025-07-23 |
Family
ID=64183836
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021546487A Active JP7712207B2 (ja) | 2018-10-19 | 2019-10-18 | 新規な癌抗原及び方法 |
| JP2022173369A Active JP7762132B2 (ja) | 2018-10-19 | 2022-10-28 | 新規な癌抗原及び方法 |
| JP2024212437A Pending JP2025041678A (ja) | 2018-10-19 | 2024-12-05 | 新規な癌抗原及び方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022173369A Active JP7762132B2 (ja) | 2018-10-19 | 2022-10-28 | 新規な癌抗原及び方法 |
| JP2024212437A Pending JP2025041678A (ja) | 2018-10-19 | 2024-12-05 | 新規な癌抗原及び方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US12263216B2 (https=) |
| EP (1) | EP3866827A1 (https=) |
| JP (3) | JP7712207B2 (https=) |
| KR (1) | KR20210080372A (https=) |
| CN (2) | CN119978090A (https=) |
| AU (1) | AU2019360427A1 (https=) |
| BR (1) | BR112021006941A2 (https=) |
| CA (1) | CA3112427A1 (https=) |
| EA (1) | EA202191081A1 (https=) |
| IL (1) | IL282308A (https=) |
| MX (1) | MX2021004453A (https=) |
| WO (1) | WO2020079448A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112021006941A2 (pt) | 2018-10-19 | 2021-08-31 | The Francis Crick Institute Limited | Antígenos de câncer inovadores e métodos |
| AU2020302285A1 (en) * | 2019-06-28 | 2021-12-02 | Enara Bio Limited | Novel cancer antigens and methods |
| CN116057067A (zh) * | 2020-04-17 | 2023-05-02 | 弗朗西斯·克里克研究所有限公司 | 用于治疗黑素瘤的ctl抗原的融合蛋白 |
| JP2023522193A (ja) * | 2020-04-17 | 2023-05-29 | ザ フランシス クリック インスティチュート リミティッド | 抗原プール |
Family Cites Families (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002515734A (ja) | 1996-01-02 | 2002-05-28 | カイロン コーポレイション | 遺伝子改変された樹状細胞により媒介される免疫刺激 |
| US6770456B1 (en) | 1998-07-29 | 2004-08-03 | Ludwig Institute For Cancer Research | Endogenous retrovirus tumor associated nucleic acids and antigens |
| US7504490B1 (en) | 1998-10-16 | 2009-03-17 | Oscient Pharmaceuticals Corporation | Nucleic acid and amino acid sequences relating to Apergillus fumigatus for diagnostics and therapeutics |
| AU2001238347A1 (en) | 2000-02-28 | 2001-09-12 | Hyseq, Inc. | Novel nucleic acids and polypeptides |
| US6436703B1 (en) | 2000-03-31 | 2002-08-20 | Hyseq, Inc. | Nucleic acids and polypeptides |
| US20020015998A1 (en) | 2000-04-06 | 2002-02-07 | Gabriel Vogeli | Novel G protein-coupled receptors |
| US20020082206A1 (en) | 2000-05-30 | 2002-06-27 | Leach Martin D. | Novel polynucleotides from atherogenic cells and polypeptides encoded thereby |
| US20040142325A1 (en) | 2001-09-14 | 2004-07-22 | Liat Mintz | Methods and systems for annotating biomolecular sequences |
| US7193069B2 (en) | 2002-03-22 | 2007-03-20 | Research Association For Biotechnology | Full-length cDNA |
| JP2003304877A (ja) | 2002-04-15 | 2003-10-28 | Keio Gijuku | ヒト色素細胞特異分子 |
| WO2004038003A2 (en) | 2002-10-25 | 2004-05-06 | Five Prime Therapeutics, Inc. | Human polypeptides encoded by polynucleotides and methods of their use |
| EP1586330A1 (en) | 2004-04-16 | 2005-10-19 | Georg-August-Universität Göttingen | Vaccination against malignant melanoma |
| DK1871391T3 (da) | 2005-03-30 | 2012-04-16 | Viroxis | Endogen retrovirus og proteiner, der kodes af env som target for cancerbehandling |
| WO2006105642A1 (en) | 2005-04-05 | 2006-10-12 | British Columbia Cancer Agency | Biomarkers for the detection of lung cancer and uses thereof |
| AT502292B1 (de) | 2005-05-11 | 2010-04-15 | Avir Green Hills Biotechnology | Melanomdiagnose |
| US20070072175A1 (en) | 2005-05-13 | 2007-03-29 | Biogen Idec Ma Inc. | Nucleotide array containing polynucleotide probes complementary to, or fragments of, cynomolgus monkey genes and the use thereof |
| EP1963534A2 (en) | 2005-12-19 | 2008-09-03 | Genizon Biosciences Inc. | Genemap of the human gene associated with crohn's disease |
| US8921050B2 (en) | 2006-03-17 | 2014-12-30 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Methods of diagnosing renal cell carcinoma |
| US20090297530A1 (en) | 2006-05-22 | 2009-12-03 | Feng Wang-Johanning | Herv-k antigens, antibodies, and methods |
| US20080019979A1 (en) | 2006-05-22 | 2008-01-24 | Feng Wang-Johanning | HERV-K Antigens, Antibodies, and Methods |
| US20100120627A1 (en) | 2006-08-02 | 2010-05-13 | Abdelmajid Belouchi | Genemap of the human genes associated with psoriasis |
| EP2118320A4 (en) | 2007-02-06 | 2010-05-19 | Genizon Biosciences Inc | GENE CARD OF HUMAN GENES ASSOCIATED WITH HYPERACTIVITY ATTENTION DEFICIT DISORDER (ADHD) |
| US8541553B2 (en) | 2007-05-24 | 2013-09-24 | Baxter Healthcare Sa | Antibodies specific for the melanoma-associated endogenous retrovirus (MERV) envelope glycoprotein |
| WO2009026116A2 (en) | 2007-08-16 | 2009-02-26 | Genizon Biosciences, Inc. | Genemap of the human genes associated with longevity |
| WO2009039244A2 (en) | 2007-09-18 | 2009-03-26 | Genizon Biosciences Inc. | Genemap of the human genes associated with crohn's disease |
| EP2340851A4 (en) | 2008-09-18 | 2012-09-26 | Univ Keio | DIAGNOSTIC METHOD AND THERAPEUTIC METHOD FOR CANCER |
| WO2013040142A2 (en) | 2011-09-16 | 2013-03-21 | Iogenetics, Llc | Bioinformatic processes for determination of peptide binding |
| TW201326481A (zh) | 2011-08-30 | 2013-07-01 | Nat Defense Medical Ct | 預測易罹患卵巢贅瘤或卵巢癌預後之生物標記 |
| FR2984362B1 (fr) | 2011-12-20 | 2017-11-24 | Biomerieux Sa | Procede pour le diagnostic ou le pronostic in vitro du cancer du poumon |
| WO2014004385A2 (en) | 2012-06-25 | 2014-01-03 | Board Of Regents, The University Of Texas System | Anti-cancer vaccines |
| ES2807791T3 (es) | 2014-12-08 | 2021-02-24 | Univ Michigan Regents | ARN no codificantes y usos de los mismos |
| GB201521894D0 (en) | 2015-12-11 | 2016-01-27 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides for use in immunotherapy against various cancers |
| CR20180551A (es) | 2016-04-21 | 2019-02-12 | Immatics Biotechnologies Gmbh | Inmunoterapia contra el melanoma y otros tipos de cáncer |
| EP3576751A4 (en) | 2017-02-01 | 2021-08-04 | ModernaTX, Inc. | RNA ANTI-CANCER VACCINES |
| BR112021006941A2 (pt) | 2018-10-19 | 2021-08-31 | The Francis Crick Institute Limited | Antígenos de câncer inovadores e métodos |
| AU2020302285A1 (en) | 2019-06-28 | 2021-12-02 | Enara Bio Limited | Novel cancer antigens and methods |
| MX2021015766A (es) | 2019-06-28 | 2022-01-27 | The Francis Crick Institute Ltd | Nuevos antigenos y metodos contra el cancer. |
| WO2021005338A2 (en) | 2019-07-05 | 2021-01-14 | The Francis Crick Institute Limited | Novel cancer antigens and methods |
| JP7834016B2 (ja) | 2019-07-05 | 2026-03-23 | ザ フランシス クリック インスティチュート リミティッド | 新規な癌抗原及び方法 |
-
2019
- 2019-10-18 BR BR112021006941-0A patent/BR112021006941A2/pt not_active IP Right Cessation
- 2019-10-18 MX MX2021004453A patent/MX2021004453A/es unknown
- 2019-10-18 WO PCT/GB2019/052980 patent/WO2020079448A1/en not_active Ceased
- 2019-10-18 CN CN202411985215.3A patent/CN119978090A/zh active Pending
- 2019-10-18 KR KR1020217010920A patent/KR20210080372A/ko not_active Ceased
- 2019-10-18 EP EP19790765.2A patent/EP3866827A1/en active Pending
- 2019-10-18 CA CA3112427A patent/CA3112427A1/en active Pending
- 2019-10-18 EA EA202191081A patent/EA202191081A1/ru unknown
- 2019-10-18 CN CN201980068630.3A patent/CN112867501B/zh active Active
- 2019-10-18 JP JP2021546487A patent/JP7712207B2/ja active Active
- 2019-10-18 AU AU2019360427A patent/AU2019360427A1/en not_active Abandoned
-
2021
- 2021-04-13 IL IL282308A patent/IL282308A/en unknown
- 2021-04-16 US US17/232,597 patent/US12263216B2/en active Active
-
2022
- 2022-10-28 JP JP2022173369A patent/JP7762132B2/ja active Active
-
2024
- 2024-12-05 JP JP2024212437A patent/JP2025041678A/ja active Pending
-
2025
- 2025-02-25 US US19/062,913 patent/US20250360206A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Arab et al. | HER2-positive breast cancer immunotherapy: a focus on vaccine development | |
| Liu et al. | Cancer vaccines as promising immuno-therapeutics: platforms and current progress | |
| Sun et al. | Nanomedicine and macroscale materials in immuno-oncology | |
| Molino et al. | Viral-mimicking protein nanoparticle vaccine for eliciting anti-tumor responses | |
| JP7670445B2 (ja) | 癌の予防及び治療のための抗原性ペプチド | |
| KR101323540B1 (ko) | 암의 치료제 | |
| Cai et al. | Improving cancer vaccine efficiency by nanomedicine | |
| JP7116278B2 (ja) | 癌治療のための免疫原性化合物 | |
| JP2001524928A (ja) | クロスプライミング免疫による天然抗原に特異性を有するｃｔｌの誘導 | |
| JP2006523688A (ja) | ヌクレオチド・ワクチン組成、ヌクレオチド及び細胞ワクチン組成の産出方法、ワクチン組成、ワクチン組成使用、免疫反応産出方法、疾患の治療または予防方法、抗原提示細胞から成るキット | |
| CN110124018A (zh) | 一种模拟坏死肿瘤细胞的磷酸钙-脂质纳米疫苗及其应用 | |
| ES2900262T3 (es) | Un medicamento para el uso en un método para inducir o extender una respuesta inmunitaria citotóxica celular | |
| Emens et al. | Cancer vaccines: an old idea comes of age | |
| CN101146550A (zh) | 用于预防或治疗目的的激发、增强和维持对i类mhc-限制性表位的免疫应答的方法 | |
| Zhang et al. | A Milestone in the Shift from “Passive Killing” to “Active Immunomodulation” in Cancer Treatment—Progress in Melanoma Vaccine Research | |
| WO2017177907A1 (zh) | 抗免疫检查点pd-l1和pd-l2肿瘤疫苗 | |
| JPWO2020079448A5 (https=) | ||
| JPWO2021005339A5 (https=) | ||
| JPWO2021005338A5 (https=) | ||
| JPWO2020260897A5 (https=) | ||
| JPWO2020260898A5 (https=) | ||
| CN112011833A (zh) | 筛选和分离肿瘤新生抗原的方法 | |
| US20110104101A1 (en) | Immunotherapy for Unresectable Pancreatic Cancer | |
| JP2022542320A (ja) | ペプチドがロードされたキャリアシステムおよびその使用 | |
| Xie et al. | An mRNA Tumor Nanovaccine Expressing Tumor Antigen Fused With Angiotensin II Facilitates Type 1 Conventional Dendritic Cell‐Mediated Anti‐Tumor Immunity |